HERON
HERON THERAPEUTICS, INC. /DE/
Quick answer
HERON is a pharma company (HRTX) headquartered in SAN DIEGO, CA, USA with 18 tracked pipeline programs.
Pipeline (18)
APF530
Chemotherapy-induced Nausea and Vomiting
1 trials projectAPF530
Nausea and Vomiting
1 trials projectAprepitant injectable emulsion
COVID-19
1 trials projectB10 L-BPA Injection
Malignant Brain Tumors
1 trials projectB10 L-BPA Injection
Meningioma
1 trials projectBupivacaine HCI without epinephrine
Post-Operative Pain
1 trials projectDrug: B10 L-BPA Injection
Head and Neck Cancer
1 trials projectGRANISETRON EXTENDED RELEASE INJECTION (GERSC)
Chemotherapy-induced Nausea and Vomiting
1 trials projectHTX-011A
Postoperative Pain
1 trials projectHTX-011B
Postoperative Pain
1 trials projectHTX-034
Bunions
1 trials projectBupivacaine HCl
Analgesia
1 trials projectBupivacaine Hydrochloride
Analgesia
1 trials projectBupivacaine liposome injectable suspension
Analgesia
1 trials projectHTX-011
Postoperative Pain
8 trials projectHTX-011
Analgesia
6 trials projectSUSTOL
Chemotherapy-Induced Nausea and Vomiting (CINV)
1 trials projectZYNRELEF 200Mg-6Mg Extended-Release Solution
Post Operative Pain, Acute
1 trialsDrugs (2)
Patents (8)
US 12318376
Compositions of a polyorthoester and an aprotic solvent
patentUS 12290520
Methods of use of emulsion formulations of aprepitant
patentUS 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
patentUS 12115254
Methods of use of emulsion formulations of an NK-1 receptor antagonist
patentUS 11878074
Methods of use of emulsion formulations of an NK-1 receptor antagonist
patentUS 11844837
Compositions of a polyorthoester and an organic acid excipient
patentUS 11744800
Methods of use of emulsion formulations of an NK-1 receptor antagonist
patentUS 11413350
Long-acting polymeric delivery systems